online | memorias.ioc.fiocruz.br Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 105(3): 314-317, May 2010 Helicobacter pylori is a microorganism associated with gastric pathologies, such as peptic ulcers, chronic gastritis and stomach cancer (Dunn et al. 1997) . Treat� reat� ment consists o� a triple therap� that com�ines a pro� consists o� a triple therap� that com�ines a pro� tein inhi�itor with anti�iotics, with clarithrom�cin �e� ing the �irst choice (Asaka et al. 2001 , Ri�eiro et al. 2003 �ecause it is acid�sta�le and easil� a�sor�ed in the gastric mucosa and, there�ore, e��ective against H. pylori (Megraud 2004 , Yilmaz & Demira� 2007 . Thus, resistance �� this �acterium to the anti�iotic is considered to �e one o� the major reasons �or treatment �ailure (Ylmaz & Demira� 2007.) .
Clarithrom�cin is a macrolide that has the a�ilit� to inhi�it protein s�nthesis in H. pylori �ecause o� its interaction with ri�osomal su�unit 50S in the micro� organism , Garrido & Toledo 2007 . The mechanism o� action �or clarithrom�cin is to �ind to the peptid�ltrans�erase loop in domain V o� the 23S ri�osomal RNA (rRNA) gene, which inter�eres with protein elongation, e��icientl� �locking �acterial protein s�nthesis (Yilmaz & Demira� 2007) .
It is �elieved that resistance to clarithrom�cin is a result o� structural changes in the 23S rRNA molecule that develop when a nucleotide su�stitution occurs near this ri�osome �inding site, impeding the drug �rom �inding and reducing its e��icac� (Graham & Qureshi 2000) . Mutations in domain V o� the 23S rRNA gene have �een associated with an important role in resistance to clarithrom�cin , Umegaki et al. 2000 , Rim�ara et al. 2007 ). These su�stitutions re� sult in reduced ri�osomal a��init� �or various macrolides, leading to resistance (Umegaki et al. 2000 , Rim�ara et al. 2007 . Thus, there is a �ailure in eradicating the �ac� the �ac� teria �rom the gastrointestinal tract, which complicates treatment o� gastroduodenal diseases with which the in� �ection is associated (Rim�ara et al. 2007 ).
The most prevalent and well�documented mutations in the 23S rRNA gene occur in two adjacent nucleotide positions, 2142 and 2143, and include an adenine�guanine transition at position 2142 (A2142G) or 2143 (A2143G) and an adenine�c�tosine transversion at position 2142 (A2142C) , Occhinalli et al. 1997 . Other mutations that are associated with resist� ance have occasionall� �een o�served in region V o� the 23S rRNA gene, including G1939A, A2115G, G2141A, A2144G, C2147G, T2182C, G2224A and T2215C (Stone at al. 1996 , Ta�lor et al. 1997 , Song et al. 2000 , Kim et al. 2002 , Hao et al. 2004 , Garrido & Toledo 2007 . The num�er o� mutations in this region indicates that an� alteration in this domain o� the gene ma� �e related to �acterial resistance to clarithrom�cin.
The state o� Pará (PA), in the Brazilian Amazon, has a high prevalence o� H. pylori in�ection in patients with gastric pathologies (Aguiar et al. 2002 , Martins et al. 2005 , Melo�Bar�osa et al. 2009 ). Because o� a recent increase in �ailure o� the treatment scheme �or the �ac� treatment scheme �or the �ac� scheme �or the �ac� teria due to clarithrom�cin resistance (Magalhães et al. 2002 , Hao et al. 2004 , Kim et al. 2008 , the o�jective o� this paper was to demonstrate the modi�ications in the H. pylori 23S rRNA gene isolated �rom eastern Ama� zon patients using a metagenomic approach. DNA isolation and PCR amplification -DNA �rom the samples was extracted using the phenol�chloro�orm method (Sam�rook et al. 1989) . A sample pool was creat� ed composed o� the DNA �rom individuals known to �e in�ected �� the �acteria (n = 250). Ampli�ication o� DNA �rom patient samples and the sample pool was per�ormed using primers 5'�CCACAGCGATGTGGTCTCAG�3' (position 1820�1839) and 5'�CTCCATAAGAGCCT� GACT�3' (position 2244�2225), which ampli�ied a 425� �p �ragment �rom region V o� the H. pylori 23S rRNA gene (Occhinali et al. 1997 ). The 50 µL reaction con� tained 75 mM Tris�HCl, 20 mM KCl pH 8.4, 1.5 mM MgCl 2 , 0.2 mM deox�nucleotides, 1 µM each primer, 2 U Platinum Taq DNA pol�merase (Invitrogen, Li�e Technologies) and 100 ng genomic DNA. The c�cling program corresponded to 1 c�cle at 95°C �or 5 min, 35 c�cles at 95°C �or 30 sec, 58°C �or 30 sec and 72°C �or 30 sec and a �inal extension c�cle at 72°C �or 10 min. The amplicon o� 425 �p was visualised on a 2% agarose gel.
Characterization of 23S rRNA domain V mutations in gastric biopsy patients from the eastern Amazon
Genomic sequencing -A�ter ampli�ication, the �rag� ment was excised �rom the agarose gel, puri�ied with the GE GFX kit, inserted into a pGEM ® �T Eas� Vector S�s� tem (Promega Corp, USA) �ollowing the manu�acturer's instructions and then trans�ormed �� electroporation into TOP 10 Escherichia coli. The trans�ormed �acteria were grown on plates using 2XYT culture media con� taining ampicilin (EMS, Brazil) and X�gal (GE Health Care, USA). The recom�inant clones were selected and grown in deep well plates with TARTOFF �roth contain� ing ampicilin. Recom�inant clones were isolated using a miniprep and then sequenced in a MegaBACE1000 au� tomatic isolator (GE).
Sequence analysis -The resulting sequences were aligned and manuall� edited with the ClustalW applica� tion using the Bioedit sequence alignment editor 7.0.0 � BioEdit so�tware (Hall 1999), with GenBank accession sequence U27270 as the re�erence.
RESuLTS
Sequencing o� the domain V �ragment o� the 23S rRNA gene o� H. pylori resulted in 49 reads, which were aligned and edited using the Bioedit application. Chi� meric sequences were detectedand eliminated �rom the data�ase and the remaining 41 sequences were anal�sed �or diversit�.
The domain V mutations o� the 23S rRNA gene were determined �� comparison with the re�erence strain (UA802) and we veri�ied that 75.6% (31/41) o� the o�� tained reads presented some t�pe o� nucleotide su�stitu� tion in the sequence.
Among the o�served su�stitutions, we �ound seven di��erent t�pes o� mutations in di��erent reads (Ta�le), including �our that have �een descri�ed in the literature as �eing associated with resistance to clarithrom�cin (A2143G, T2182C, T2215C and G2224). Additionall�, we �ound three novel su�stitutions not characterised in an� previousl� descri�ed population: G2204C, A2192G and T2221C. None o� the sequences had more than one nucleotide change.
The su�stitutions encountered in the sequencing reads occurred with the �ollowing prevalence: A2143G (3.3%), T2182C (12.9%), G2224A (6.45%), T2215C (61.3%), A2192G (3.3%), G2204C (6.4%) and T2221C (6.4%).
The seven sequences �ound in this stud� were su�� mitted to GenBank, generating accession GQ 395614, GQ 395615, GQ 395616, GQ 395617, GQ395618, GQ� 395619 and GQ 395620 (Ta�le).
DIScuSSION
The prevalence o� mutations �ound in domain V o� the 23S rRNA gene o� H. pylori in patients �rom the North� ern Region o� Brazil was high; 76.5% o� the o�tained se� quences presented some t�pe o� nucleotide su�stitution. According to prior studies, alterations in this domain o� the gene con�er �acterial resistance to clarithrom�cin , Occhialini et al. 1997 , Van Doorn et al. 2001 , Posteraro et al. 2006 , Kim et al. 2008 .
It is �elieved that su�stitutions �ound in this H. pylori gene ma� �e linked to the growing use o� this anti�iotic not onl� in eradicating H. pylori �ut also in treating respi� rator� tract in�ections (Megraud 1998 , Ri�eiro et al. 2003 , Posteraro et al. 2006 , which leads to anti�iotic resistant strains. Furthermore, this �acterial species has extensive rearrangements within its genome (Dunn et al. 1997 , Covacci et al. 1999 , Velázquez & Feirtag 1999 used �or adapting to hosts (Suer�aum & Josenhans 2008) , mainl� leading to development o� resistance to anti�iotics like clarithrom�cin.
Studies have demonstrated that the �requenc� o� resis� tance to this anti�iotic has varied around the world accord� ing to the geographic region and su�groups within popula� tions (Graham 1998 , Kim et al. 2008 ) and in recent �ears, a signi�icant increase in the rates o� H. pylori strains resis� tant to clarithrom�cin has �een documented (Magalhães et al. 2002 , Posteraro et al. 2006 . In Europe, resistance rates are 2�24%, while the� are 13�18% in Japan and 12� 25% in North America (Nakamura et al. 2007) . Kim et al. (2008) demonstrated an increase in cases o� resistant strains reaching 85.1% in Korea that was correlated with the reduction in �acteria in individuals in that countr�.
In Southeastern Brazil, Magalhães et al. (2002) �ound a 9.85% prevalence o� resistant strains and in the �ollow� ing �ear, Godo� et al. (2003) descri�ed an increase to 16%. In this stud�, the Northern Region has a much higher rate than the average o�served in the Southeastern Brazil� ian population, presenting �our o� the known mutations related to clarithrom�cin resistance, which ma� �e related to heterogeneit� in the H. pylori strains that colonise the di��erent regions o� Brazil (Kodaira et al. 2000) .
Four known mutations were detected in this stud�, A2143G , T2182C (Kim et al. 2002) , G2224A (Hao et al. 2004 ) and T2215C (Song et al. 2000) , with the latter �eing quite prevalent (62.95%). Also, three novel mutations were identi�ied and charac� terised in �acteria within the gastrointestinal meta�iome. Additionall�, �ecause these mutations are in the domain o� the gene normall� related to clarithrom�cin resistance , Occhialini et al. 1997 , Ri�eiro et al. 2003 , new studies must �e per�ormed using culture� dependent approaches to con�irm association o� �acte� rial anti�iotic resistance with the novel nucleotide su�� stitutions in domain V o� the 23S rRNA gene detected in this stud�.
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